Nocturnal oxygen therapy in obstructive sleep apnoea: a systematic review and meta-analysis
- PMID: 38508665
- PMCID: PMC10951857
- DOI: 10.1183/16000617.0173-2023
Nocturnal oxygen therapy in obstructive sleep apnoea: a systematic review and meta-analysis
Abstract
Obstructive sleep apnoea is characterised by recurrent reduction of airflow during sleep leading to intermittent hypoxia. Continuous positive airway pressure is the first-line treatment but is limited by poor adherence. Nocturnal oxygen therapy may be an alternative treatment for obstructive sleep apnoea but its effects remain unclear. This meta-analysis evaluates the effects of nocturnal oxygen therapy on both obstructive sleep apnoea severity and blood pressure.A literature search was performed based on the Preferred Reporting Items for Systematic Review and Meta-analysis guidelines. Peer-reviewed, randomised studies that compared the effect of nocturnal oxygen therapy to sham in obstructive sleep apnoea patients were included. The main outcomes were the apnoea-hypopnoea index and systolic and diastolic blood pressure.The search strategy yielded 1295 citations. Nine studies with 502 participants were included. When nocturnal oxygen therapy was compared to sham/air, it significantly reduced the apnoea-hypopnoea index (mean difference (MD) -15.17 events·h-1, 95% CI -19.95- -10.38 events·h-1, p<0.00001). Nocturnal oxygen therapy had no significant effect on blood pressure at follow-up without adjustment for baseline values, but did, where available, significantly attenuate the change in blood pressure from baseline to follow-up for both systolic blood pressure (MD -2.79 mmHg, 95% CI -5.45- -0.14 mmHg, p=0.040) and diastolic blood pressure (MD -2.20 mmHg, 95% CI -3.83- -0.57 mmHg, p=0.008).Nocturnal oxygen therapy reduced the apnoea-hypopnoea index severity and the change in (but not absolute) systolic and diastolic blood pressure, compared to sham. This suggests that nocturnal oxygen therapy may be a treatment option for obstructive sleep apnoea. Further studies with longer-term follow-up and standardised measurements are needed.
Copyright ©The authors 2024.
Conflict of interest statement
Conflict of interest: C. Turnbull reports honoraria from Stowood Scientific, outside the scope of this submission. There are no other relevant competing interests.
Figures
![FIGURE 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10951857/bin/ERR-0173-2023.01.gif)
![FIGURE 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10951857/bin/ERR-0173-2023.02.gif)
![FIGURE 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10951857/bin/ERR-0173-2023.03.gif)
![FIGURE 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10951857/bin/ERR-0173-2023.04.gif)
![FIGURE 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10951857/bin/ERR-0173-2023.05.gif)
Similar articles
-
Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea.Cochrane Database Syst Rev. 2020 Nov 3;11(11):CD013449. doi: 10.1002/14651858.CD013449.pub2. Cochrane Database Syst Rev. 2020. PMID: 33141943 Free PMC article.
-
Pressure modification or humidification for improving usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea.Cochrane Database Syst Rev. 2019 Dec 2;12(12):CD003531. doi: 10.1002/14651858.CD003531.pub4. Cochrane Database Syst Rev. 2019. PMID: 31792939 Free PMC article.
-
Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea.Cochrane Database Syst Rev. 2015 Jul 14;(7):CD011090. doi: 10.1002/14651858.CD011090.pub2. Cochrane Database Syst Rev. 2015. PMID: 26171909 Review.
-
Continuous positive airways pressure for obstructive sleep apnoea in adults.Cochrane Database Syst Rev. 2006 Jul 19;(3):CD001106. doi: 10.1002/14651858.CD001106.pub3. Cochrane Database Syst Rev. 2006. PMID: 16855960 Review.
-
Continuous positive airways pressure for obstructive sleep apnoea in adults.Cochrane Database Syst Rev. 2006 Jan 25;(1):CD001106. doi: 10.1002/14651858.CD001106.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2006 Jul 19;(3):CD001106. doi: 10.1002/14651858.CD001106.pub3. PMID: 16437429 Updated. Review.
Cited by
-
Hypoxia-Induced Insulin Resistance Mediates the Elevated Cardiovascular Risk in Patients with Obstructive Sleep Apnea: A Comprehensive Review.Rev Cardiovasc Med. 2024 Jun 25;25(6):231. doi: 10.31083/j.rcm2506231. eCollection 2024 Jun. Rev Cardiovasc Med. 2024. PMID: 39076340 Free PMC article. Review.
References
-
- National Institute for Health and Care Excellence . Continuous positive airway pressure for the treatment of obstructive sleep apnoea/hypopnoea syndrome. 2008. www.nice.org.uk/guidance/ta139 Date last updated: 20 August 2021.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical